Acalabrutinib fda approval date 2017?

Was acalabrutinib approved by the FDA in 2017?

Yes. Acalabrutinib (Calquence) received FDA approval in 2017 [1].

What was the FDA approval date for Calquence (acalabrutinib)?

The FDA approval date listed for acalabrutinib is October 31, 2017 [1].

How can I confirm the exact approval date?

The approval date can be verified through FDA product labeling/records or reliable drug-information databases that cite the FDA approval event; both list the 2017 approval date for acalabrutinib [1].

What does that 2017 approval correspond to?

That approval is for acalabrutinib as a cancer therapy (Calquence), following FDA review of the relevant clinical data submitted by the manufacturer [1].

Sources

[1] https://www.drugs.com/fda/acalabrutinib.html